Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A steady, comfortable experience that allows you to thrive at each phase of the journey while still experiencing meaningful weight loss
Mutations in methyl-CpG binding protein 2 (MeCP2), an epigenetic regulator, are the main cause of Rett syndrome
Retatrutide has been tested in both Phase 2 and Phase 3 clinical trials involving hundreds of participants across multiple dose groups
Regular monitoring through weight tracking, measurements, and periodic bloodwork helps identify any early signs of weight regain or metabolic changes
US$ 26.32
US$ 24.98
US$ 24.06
